A phase I study of ABT 510 and concurrent temozolamide and radiotherapy for patients with newly diagnosed glioblastoma multiforme

被引：0
|
作者：
Kekan, M. [1 ]
Fiveash, J. [1 ]
Markert, J. M. [1 ]
Gillespie, G. Y. [1 ]
Kuo, H. [1 ]
Meleth, S. [1 ]
Gladson, C. L. [1 ]
Nabors, L. B. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2023
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase I study of capecitabine and concurrent radiotherapy (RT) for patients with newly diagnosed glioblastoma multiforme (GBM).
    Newman, AJ
    Fiveash, J
    Rosenfeld, S
    Johnson, M
    Diasio, R
    Wang, W
    Cockrell-Donohue, AC
    Nabors, LB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 116S - 116S
  • [2] A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
    Nabors, Louis B.
    Fiveash, John B.
    Markert, James M.
    Kekan, Manasi S.
    Gillespie, George Y.
    Huang, Zhi
    Johnson, Martin J.
    Meleth, Sreelatha
    Kuo, Huichien
    Gladson, Candece L.
    Fathallah-Shaykh, Hassan M.
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (03) : 313 - 319
  • [3] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
  • [4] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Michelle Alonso-Basanta
    Penny Fang
    Amit Maity
    Stephen M. Hahn
    Robert A. Lustig
    Jay F. Dorsey
    [J]. Journal of Neuro-Oncology, 2014, 116 : 365 - 372
  • [5] Phase II study of temozolamide in patients with glioblastoma multiforme
    Janinis, J
    Tsantila, A
    Samantas, E
    Aravantinos, G
    Sitaras, N
    Skarlos, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 181 - 181
  • [6] A PILOT SAFETY STUDY OF LENALIDOMIDE AND RADIOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Drappatz, Jan
    Wong, Eric T.
    Schiff, David
    Kesari, Santosh
    Batchelor, Tracy T.
    Doherty, Lisa
    LaFrankie, Debra Conrad
    Ramakrishna, Naren
    Weiss, Stephanie
    Smith, Sharon T.
    Ciampa, Abigail
    Zimmerman, Jennifer
    Ostrowsky, Louis
    David, Karly
    Norden, Andrew
    Barron, Loretta
    Sceppa, Christine
    Black, Peter M.
    Wen, Patrick Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 222 - 227
  • [7] Oral Temozolamide concurrent with radical radiotherapy for patients with glioblastoma multiforme: The University Hospitals of Leicester Experience
    Gore, A.
    Boiangiu, I.
    Symonds, R. P.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 233 - 233
  • [8] PHASE 1 STUDY EVALUATING ABT-414 WITH CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Gan, H. K.
    Fichtel, L.
    Lassman, A.
    Merrell, R.
    van den Bent, M. J.
    Kumthekar, P.
    Scott, A.
    Pedersen, M.
    Gomez, E.
    Fischer, J.
    Ames, W.
    Xiong, H.
    Dudley, M.
    Roberts-Rapp, L.
    Ansell, P. J.
    Holen, K.
    Reardon, D. A.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [9] Role of Intensity Modulated Radiotherapy with Concurrent and Adjuvant Chemotherapy With Temozolamide in Glioblastoma Multiforme
    Gill, J.
    Mishra, A.
    Medhashri, S.
    Kaur, P.
    Mishra, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
12345